Filing Analysis
Regulation FD Disclosure
Filed Mar 31, 2026
LOW
GoHealth, Inc. announced its financial results for the fiscal year ended December 31, 2025, via a press release issued on March 31, 2026. The filing is a routine disclosure of annual operational performance and financial condition.
Key Facts
- Financial results cover the twelve months ended December 31, 2025.
- The press release was furnished as Exhibit 99.1 under Item 2.02.
- The report was signed by Brendan Shanahan, Chief Financial Officer, on March 31, 2026.
Delisting Notice
Filed Mar 20, 2026
HIGH
GoHealth, Inc. received a deficiency notice from Nasdaq on March 18, 2026, for failing to maintain the minimum market value of listed securities (MVLS) of $35 million. The company also failed to meet alternative listing requirements related to stockholders' equity and net income, and has 180 days to regain compliance.
Red Flags
- Market value has dropped below the $35 million threshold.
- Failure to meet multiple alternative listing criteria (equity and net income), indicating broader financial weakness.
- Risk of delisting if market valuation does not recover by September 2026.
Key Facts
- Notice received from Nasdaq Listing Qualifications Department on March 18, 2026.
- Non-compliance with Nasdaq Listing Rule 5550(b)(2) requiring a minimum MVLS of $35 million.
- Company also fails alternative standards under Rules 5550(b)(1) (stockholders' equity of $2.5 million) and 5550(b)(3) (net income of $500,000).
- Compliance period of 180 calendar days granted, expiring on September 14, 2026.
- To regain compliance, MVLS must close at $35 million or more for at least 10 consecutive business days.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.